21
Integrating NCD interventions: PSI’s experiences to date Rebecca Firestone, ScD, MPH May 1, 2012

New Frontiers in NCDs_Firestone_5.1.12

Embed Size (px)

Citation preview

Page 1: New Frontiers in NCDs_Firestone_5.1.12

Integrating NCD interventions:

PSI’s experiences to date

Rebecca Firestone, ScD, MPH

May 1, 2012

Page 2: New Frontiers in NCDs_Firestone_5.1.12

PSI is a leading global health organization - social

marketing is the core of our work

Social marketing is about making it easy for people to

change their behavior

PSI reaches our target audience where they are

– Most people in the developing world get healthcare through

the private sector

– PSI leverages the private sector - providing training, new

tools, and franchised clinics

We focus on measurement, learning and innovation

Operations in 67 countries

What is PSI

Page 3: New Frontiers in NCDs_Firestone_5.1.12

Zimbabwe LesothoMalawi

BotswanaNamibiaUganda

ZambiaSwazilandCongo-Kinshasa

MozambiqueKenya

Tanzania

South Africa CameroonMadagascarRwanda

Benin Cote d'Ivoire MaliBurundiNigeriaEthiopiaAngola

Togo

MyanmarPakistan

LiberiaCambodiaC.A.R.Guinea South Sudan

Cote d'Ivoire (AIMAS)Haiti

Nepal IndiaTajikistan

Papua New GuineaLaosThailand Burkina Faso

Paraguay

Mexico

Costa Rica

Romania

PSI Global

0%

10%

20%

30%

40%

50%

60%

70%

0% 1% 2% 3% 4% 5% 6% 7% 8% 9% 10% 11% 12% 13% 14%

BO

D A

dd

res

se

d b

y P

SI P

latf

orm

(R

ele

va

nce

)

National BOD Averted

2011 PSI Platform Relevance and Impact

>= 50% Relevance

40% - 49% Relevance

30% to 39% Relevance

20% to 29% Relevance

< 20% Relevance

PSI Global

Page 4: New Frontiers in NCDs_Firestone_5.1.12

0%

10%

20%

30%

40%

50%

60%

70%

80%

90%

100%

Zim

babw

e

Lesoth

o

Mala

wi

Bots

wana

Nam

ibia

Uganda

Za

mbia

Sw

azila

nd

Congo-K

inshasa

Mozam

biq

ue

Kenya

Ta

nzania

South

Afr

ica

Cam

ero

on

Madagascar

Rw

anda

Benin

Cote

d'Ivo

ire

(p

lus A

IMA

S)

Mali

Buru

ndi

Nig

eria

Eth

iopia

Angola

To

go

Myanm

ar

Pakis

tan

Lib

eria

Cam

bodia

C.A

.R.

Guin

ea

South

Sudan

Haiti

PS

I G

lobal

Nepal

India

Ta

jikis

tan

Dom

inic

an R

epublic

Hondura

s

Guate

mala

Papua N

ew

Guin

ea

Laos

Th

aila

nd

Burk

ina F

aso

Beliz

e

Vie

tnam

Carib

bean

Pa

na

ma

Nic

ara

gua

Kyrg

yzsta

n

Para

guay

El S

alv

ador

Kazakhsta

n

Mexic

o

Chin

a

Costa

Ric

a

Russia

Rom

ania

PSI Relevance: 2011 Global DALYs Averted Compared to Burden of Disease (WHO 2004)

Innovation in NCDs + Injuries

Innovation in communicable burden

Expansion

Relevance

% DALYs Averted by PSI

% of National BODranked by % relevance

Page 5: New Frontiers in NCDs_Firestone_5.1.12

Our experience to date

Page 6: New Frontiers in NCDs_Firestone_5.1.12

Screening, diagnosis and management of gestational diabetes

in Nicaragua

Page 7: New Frontiers in NCDs_Firestone_5.1.12

Operating in 3 public sector clinics and 1 maternity hospital in

urban and per-urban Managua

Train public health care providers on risk factors for GDM; how

to screen for and detect GDM; proper management and care of

GDM

Establish formal referral and feedback systems between clinics

and hospitals for improved detection and management of GDM

Screen 750 pregnant women/month between 24-30 weeks of

gestational age for gestational diabetes

Enroll women with gestational diabetes in a management

program

– Nutritional therapy sessions, individual and group counseling for women

and their families, GDM management guide, follow-up reminders via

mobile SMS

Program strategies

Page 8: New Frontiers in NCDs_Firestone_5.1.12

Screen for ≥1 risk factor through clinical interview

– Overweight

– Family history of diabetes

– Unfavorable obstetric outcomes including: GDM or pre-diabetes in previous

pregnancies, 2 consecutive miscarriages, fetal death without an apparent

cause, macrosomia

Diagnose GDM: fasting oral glucose tolerance test in the 24th week with

75g of glucose (with 8 hours of fasting prior to the test)

– Fasting glucose ≥92 mg/dl

– 1 h ≥180 mg/dl

– 2 h ≥153 mg/dl

– Nutritional counseling during wait time

Screening protocols in a low-resource setting

Page 9: New Frontiers in NCDs_Firestone_5.1.12

Leverage existing RH connections with

government, provider networks, and medical

associations

Maximize current capabilities in

– Training health care providers using behavior change

strategies

– Quality assurance

– Behavior change communications for women via mHealth

Key challenges

– Low levels of knowledge about GDM among pregnant

women

– Inconsistent information provided to women with GDM

across internist, gynecologist, nutritionist

Lessons learned so far

Page 10: New Frontiers in NCDs_Firestone_5.1.12

Cervical cancer screening and treatment in Myanmar

Page 11: New Frontiers in NCDs_Firestone_5.1.12

Build off of existing family planning platform

– Link to provision of IUDs and other contraceptives

Train 47 providers in VIA at 47 franchises

Train 10 providers in cryotherapy

– Hub and spoke approach to direct women from screening to

treatment sites

Aim to

– Screen 20,000 women

– Treat 2,000 women with cryo

– Prevent 300 cases of cervical cancer

PSI Health Impact Model estimates that 10,000

women screened and treated = 1,006 DALYs

Piloting VIA + cryotherapy in a social franchise

Page 12: New Frontiers in NCDs_Firestone_5.1.12

Social franchise network provides a flexible platform

to integrate a range of services

Need for advocacy with the medical professional

community

– Task-shifting from OB/Gyn to GPs

– Proving sensitivity/specificity of VIA, safety/efficacy of cryo to

local stakeholders

Challenges in procuring equipment

– High costs of cryo guns

– Delays in receiving import licenses

Lessons learned so far

Page 13: New Frontiers in NCDs_Firestone_5.1.12

Where we want to be going

Page 14: New Frontiers in NCDs_Firestone_5.1.12

Tuberculosis and Tobacco

Page 15: New Frontiers in NCDs_Firestone_5.1.12

More than 20% of global TB incidence may be attributable to

smoking tobacco

PSI TB programs in 12 countries

– Screening and treatment through social franchises

• 91% treatment completion in Pakistan; 85% completion in

Myanmar

– Screening and referral linked to HIV TC centers

• 91% of HIV testing clients screened for TB in Zimbabwe

Aim for smoke-free facilities

Identify and assess tobacco use status among TB clients

– WHO “5 A’s” algorithm for those willing to quit

– Who “5 R’s” motivational intervention to promote quitting

Integrate tobacco messaging into community outreach to TB

clients and families

Tuberculosis and tobacco

Page 16: New Frontiers in NCDs_Firestone_5.1.12

An expanded approach to cervical cancer

Page 17: New Frontiers in NCDs_Firestone_5.1.12

Into reproductive health programs

– Scaling up screen+treat via social franchises

– Establish mobile services

– Introduce HPV vaccination (Nicaragua)

Into HIV testing and counseling (HTC)

– PSI operates HIV testing and counseling in 30 countries

– 1.4 million people tested and counseled in 2011

– Variety of modalities: social franchises, mobile clinics, stand-

alone clinics

– HTC emphasizes integration – with FP, TB. Why not

cervical cancer?

Cervical cancer service integration

Page 18: New Frontiers in NCDs_Firestone_5.1.12

An expanded approach to cervical cancer programs

Behavior change communication

– Cervical cancer screening and treatment

– Vaccine uptake

Incentivized care

– For providers and/or participants

Advocacy

– Ministries of Health and Education

– Medical professional organizations

Page 19: New Frontiers in NCDs_Firestone_5.1.12

Hypertension and diabetes: the next frontier for franchising

0102030405060708090

100

PSI

Range of franchised services provided, 2011

Page 20: New Frontiers in NCDs_Firestone_5.1.12

Challenges for SF and NCDs

Thank You!

Page 21: New Frontiers in NCDs_Firestone_5.1.12

Questions?

1 1 2 0 1 9 T H S T R E E T , N W | S U I T E 6 0 0

W A S H I N G T O N , D C 2 0 0 3 6

P S I . O R G | T W I T T E R : @ P S I H E A LT H Y L I V E S | B L O G : P S I H E A LT H Y L I V E S . C O M

PSI